Clinical trials give our researchers and clinicians crucial evidence about the effect of new or experimental cancer treatments to guide our advances in cancer care. For patients like John Mailes, diagnosed in 2001 with a rare cancer which at that time had no effective treatment, a clinical trial can also deliver a new lease on life.
Peter Mac and Monash Health are working together as part of an international trial to provide single-dose radiation therapy to woman at the same time they undergo surgery for breast cancer. The trial of intra-operative radiation therapy (IORT) allows women to receive their required radiation dose in less than ten minutes, in a procedure that occurs during surgery to remove their tumour.
Peter Mac's Professor Mark Dawson has been selected as a Howard Hughes Medical Institute (HHMI) International Research Scholar. The scholarship recognises Prof Dawson as a leading early-career scientist working outside of the G7 group of countries.
12,000+ Australians diagnosed with blood cancers each year could soon have access to a simple blood test to monitor their disease thanks to a world-first ‘liquid biopsy’ developed at Peter MacCallum Cancer Centre.
Dr Vihandha Wickramasinghe’s paradigm-shifting research focuses on understanding the fundamental biology of gene expression and how it is altered in the development of cancer cells. The goal is to find new ways to intervene when normal quality control processes within the cell go awry.
Researchers at Peter MacCallum Cancer Centre and Monash University and have identified for the first time how a new class of epigenetic drug engages with the immune system to kill off cancer cells, offering powerful new pathways for enhanced blood cancer therapies.
Peter MacCallum Cancer Centre will join Bristol Myers Squibb’s International Immuno-Oncology Network (II-ON) – a peer-to-peer network that aims to accelerate the advancement of cancer immunotherapies, the emerging “fourth pillar” of cancer treatment.
Peter MacCallum Cancer Centre welcomes the latest round of Victorian Cancer Agency (VCA) grants which included a further $5.2million for our research and clinical trials into areas of great community need such as Advanced Melanoma, Prostate Cancer, Head and Neck Cancer; and Acute Myeloid Leukaemia.
An international scientific collaboration involving Peter MacCallum Cancer Centre, University College London, Birkbeck College (London) and Monash University has visualised in microscopic detail how the natural defence force within our immune system attacks and destroys harmful invaders such as virus-infected and cancerous cells.
The Peter MacCallum Cancer Centre acknowledges the traditional
owners of the land on which our five sites are located throughout Victoria.
We recognise their strength and resilience and pay our respects
to their Elders past and present.